Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Cohort Analysis
100%
Malignant Neoplasm
68%
Quality of Life
45%
Breast Cancer
40%
Nonalcoholic Fatty Liver
37%
Hazard Ratio
34%
middle age
28%
Cross Sectional Study
27%
Prevalence
25%
Lung Cancer
24%
Patient-Reported Outcome
23%
Chronic Obstructive Pulmonary Disease
21%
Non Small Cell Lung Cancer
21%
Diseases
20%
Hepatocellular Carcinoma
19%
Odds Ratio
18%
Vasomotor
17%
Cardiovascular Disease
17%
Oncologist
17%
Cardiovascular System
16%
Coronary Artery Calcium
16%
Cancer Screening
14%
Body Mass Index
14%
Physical Activity
13%
Overall Survival
13%
Outcome Assessment
13%
Health Care Cost
13%
Premenopause
13%
Diabetes
13%
Intensive Care Unit
12%
Chronic Kidney Disease
12%
Randomized Controlled Trial
12%
Cancer Diagnosis
12%
Climacterium
12%
Retrospective Cohort Study
12%
Cancer Recurrence
11%
Abdominal Cancer
11%
Percutaneous Coronary Intervention
10%
All Cause Mortality
10%
Recurrent Disease
10%
Lung
9%
Cancer Therapy
9%
Comorbidity
9%
Blood Pressure
9%
National Health and Nutrition Examination Survey
8%
Hospital Mortality
8%
Second Cancer
8%
Postmenopause
8%
Prospective Cohort Study
8%
Adverse Event
8%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
75%
Malignant Neoplasm
45%
Nonalcoholic Fatty Liver
33%
Chronic Obstructive Lung Disease
24%
Breast Cancer
22%
Prevalence
20%
Lung Cancer
20%
Diseases
18%
Non Small Cell Lung Cancer
15%
Cardiovascular Disease
15%
Heart Infarction
12%
Liver Cell Carcinoma
12%
All Cause Mortality
10%
Overall Survival
10%
Acute Heart Infarction
10%
Congestive Heart Failure
10%
Fatty Liver
10%
Recurrent Disease
9%
Cross Sectional Study
8%
Chemoradiation Therapy
7%
Chronic Hepatitis B
6%
Prospective Cohort Study
6%
Liotrix
6%
Thyroid Hormone
6%
Chronic Kidney Failure
6%
Liver Disease
6%
Randomized Controlled Trial
6%
Alopecia
5%
Hospital Acquired Pneumonia
5%
Comorbidity
5%
Cancer Recurrence
5%
Fibrosis
5%
Hospital Mortality
5%
Antiplatelet
5%
Chemotherapy
5%
Nursing and Health Professions
Malignant Neoplasm
48%
Quality of Life
32%
Breast Cancer
20%
Patient-Reported Outcome
19%
Confidence Interval
17%
Prevalence
17%
Cohort Analysis
14%
Odds Ratio
14%
Oncologist
13%
Nonalcoholic Fatty Liver
11%
Cancer Therapy
10%
Outcome Assessment
9%
Information Systems
8%
Diseases
7%
Internal Consistency
7%
Cross-Sectional Study
6%
Cancer Center
6%
Cancer Diagnosis
6%
Cancer Screening
5%
Exploratory Factor Analysis
5%
Tertiary Care Center
5%